BlackRock Advisors’s Filana Therapeutics FLNA Stock Holding History

BlackRock Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5K	Hold	1,248	–	–	﹤0.01%	3634
2016 Q3	$9K	Hold	1,248	–	–	﹤0.01%	3589
2016 Q2	$19K	Hold	1,248	–	–	﹤0.01%	3456
2016 Q1	$19K	Hold	1,248	–	–	﹤0.01%	3441
2015 Q4	$15K	Hold	1,248	–	–	﹤0.01%	3560
2015 Q3	$16K	Hold	1,248	–	–	﹤0.01%	3565
2015 Q2	$15K	Sell	1,248 -2,625	-68%	-$36K	﹤0.01%	3561
2015 Q1	$51K	Buy	3,873 +362	+10%	+$4.88K	﹤0.01%	3242
2014 Q4	$50K	Hold	3,511	–	–	﹤0.01%	3275
2014 Q3	$96K	Hold	3,511	–	–	﹤0.01%	3026
2014 Q2	$141K	Buy	3,511 +2,238	+176%	+$82.8K	﹤0.01%	2853
2014 Q1	$49K	Sell	1,273 -10,508	-89%	-$371K	﹤0.01%	3262
2013 Q4	$401K	Sell	11,781 -8,848	-43%	-$235K	﹤0.01%	2196
2013 Q3	$393K	Hold	20,629	–	–	﹤0.01%	2099
2013 Q2	$319K	Buy	+20,629	New	+$436K	﹤0.01%	2158

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ZIM

Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

BlackRock Advisors's FLNA Position: Q4 2016 in Review

BlackRock Advisors held its Filana Therapeutics (FLNA) position steady in Q4 2016 at 1,248 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

BlackRock Advisors first reported a position in FLNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $401K in Q4 2013. 46 funds tracked by Wall St. Rank hold FLNA as of Q4 2016.

BlackRock Advisors held 1,248 shares of Filana Therapeutics worth $5K as of Q4 2016.
BlackRock Advisors left its Filana Therapeutics share count unchanged in Q4 2016.
Filana Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3634 holding.
BlackRock Advisors first reported a position in Filana Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Filana Therapeutics position peaked at $401K in Q4 2013.
46 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.